EMA Authorised: Actelsar HCT (telmisartan;hydrochlorothiazide) — Actavis Group PTC ehf

View source ↗

Summary

The European Medicines Agency has authorised Actelsar HCT, a fixed-dose combination of telmisartan and hydrochlorothiazide, for essential hypertension, with mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Actelsar HCT (telmisartan/hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Essential Hypertension. MAH: Actavis Group PTC ehf. Decision date: 08/05/2025